Transplant News and Research

RSS

HRSA ranks UCLA's heart transplant program as best in the U.S.

A new survey by an agency of the U.S. Department of Health and Human Resources has recognized the heart transplant program at Ronald Reagan UCLA Medical Center as the nation's best.

13 Dec 2010

CTCs in metastatic breast cancer patients linked to cancer recurrence, poor survival rates

Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor outcomes, according to researchers from the University of Texas MD Anderson Cancer Center.

13 Dec 2010

Researchers generate insulin-secreting pancreatic islet cells from human SSCs

Insulin-secreting pancreatic islet cells have been generated from human spermatogonial stem cells (SSCs) directly isolated from human testicular tissue, researchers reported today at the American Association of Cell Biology 50th Annual Meeting in Philadelphia.

13 Dec 2010

Stem cell therapy can reduce risk of acute leukemia in affected individuals

Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.

13 Dec 2010

Arizona's transplant funding cuts continue to trigger controversy; Florida, Kansas focus on state role in reforms; Wisc. plan would elminate tax on health savings accounts

[Arizona Gov. Jane] Brewer's transplant cutbacks have become a rallying cause for Democrats, who call her decision "Brewercare." It's hypocritical for Republicans to support the program's end while opposing President Barack Obama's health-care legislation on the ground it would create death panels run by bureaucrats, said Anna Tovar, a Democratic state representative from Tolleson (Palmeri, 12/10).

10 Dec 2010

OPTN arranges first paired donation of living donor kidneys

Kathy Niedzwiecki of Pelham, NH, and Ken Crowder of St. Louis are experiencing renewed life and health thanks to the generosity of two living kidney donors.

10 Dec 2010

OpEds: Palin on the Ryan Roadmap, Seniors and primary care docs, Arizona transplant controversy

[The president's National Commission on Fiscal Responsibility and Reform's report] implicitly endorses the use of 'death panel'-like rationing by way of the new Independent Payments Advisory Board—making bureaucrats, not medical professionals, the ultimate arbiters of what types of treatment will (and especially will not) be reimbursed under Medicare.

10 Dec 2010

HeartWare prices public offering of convertible senior notes due 2017

HeartWare International, Inc. announced today the pricing of a public offering of $125 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") yesterday.

10 Dec 2010

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

A new study shows that the addition of everolimus (Afinitor® tablets) to the hormonal therapy tamoxifen in patients with hormone-receptor positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer who have been previously treated with an aromatase inhibitor (AI) delays disease progression compared to tamoxifen alone. These results were presented today at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium in San Antonio, Texas.

10 Dec 2010

Harvard Bioscience files two major patents in regenerative medicine

Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.

From Harvard Bioscience 10 Dec 2010

State roundup: Facing budget 'cliff'; Medicaid woes; Arizona transplant program; Another Florida health vote?

U.S. states are preparing for more budget cuts next year as tax revenue isn't likely to rebound enough to replace almost $38 billion in aid that will be gone as federal economic stimulus ends, according to a report. At least 31 states and Puerto Rico are forecasting deficits of $82.1 billion in the next fiscal year even as tax receipts are picking up, the National Conference of State Legislatures said today.

10 Dec 2010

New three-drug combination may be effective for newly diagnosed blood cancer patients: Study

A new three-drug combination used to treat the blood cancer multiple myeloma may be effective as a front-line therapy for newly diagnosed patients, according to a study led by the University of Michigan Comprehensive Cancer Center.

9 Dec 2010

HeartWare announces $100 million convertible senior notes offering

HeartWare International, Inc. announced today its intention to offer, subject to market and other conditions, $100 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") today. HeartWare also intends to grant the underwriters an option to purchase up to an additional $15 million principal amount of notes to cover over-allotments, if any.

9 Dec 2010

Arizona State Dem. lawmakers push for restoring Medicaid transplant money

The Fiscal Times: "Organ transplants are considered optional by the federal government. And in today's economic climate, 'optional' means endangered. In Arizona, the expenses for transplants are generally covered by the Arizona Health Care Cost Containment System (AHCCCS), or 'Access,' as the state's version of Medicaid is known. But since cash-strapped Arizona is having trouble covering its mandated medical costs—never mind anything else—[some] transplants, among other things, are on the chopping block" (Mackey, 12/7).

9 Dec 2010

Bioheart group to advance BRIDGE TO RECOVERY clinical trial

Bioheart, Inc. announced today that at the American Heart Association Annual Meeting, it finalized the formation of a working group. The group's focus is to advance a BRIDGE TO RECOVERY clinical trial, combining a left ventricle assist device (LVAD) and Bioheart's MyoCell adult muscle stem cell composition and Bioheart's MyoCath needle tipped catheter delivery system.

9 Dec 2010

Organovo releases data on bioprinted blood vessels

Organovo, Inc., a regenerative medicine company focused on bioprinting technology, today announced the release of data on the first fully bioprinted blood vessels. Data was presented at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) meeting in Orlando, Florida. The blood vessels were created through the use of the NovoGen MMX Bioprinter, Organovo's proprietary platform for the creation of 3D tissue constructs.

9 Dec 2010

Lung transplant saves economist from near-lethal bout of swine flu

According to the critical care experts at The Johns Hopkins Hospital who treated him, Allen Bagents, 24, of Arlington, Va., is the least likely person anyone ever expects to get sick, let alone suffer a six-week, potentially fatal bout with the swine flu, better known as H1N1 influenza.

8 Dec 2010

Three abstracts on Defibrotide presented at ASH Annual Meeting

Gentium S.p.A. today announced that three abstracts on Defibrotide were presented at the 52nd Annual Meeting and Exposition of the American Society of Hematology held at the Orange County Convention Center in Orlando, Florida, December 4-7, 2010.

8 Dec 2010

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.

8 Dec 2010

One Lambda, Luminex renew 10-year human leukocyte antigen technology development partnership

One Lambda Inc., a leading manufacturer and supplier of quality products and technology for the HLA transplant community, and Luminex Corporation have agreed to a long-term renewal of their 10-year strategic partnership aimed at developing platforms and technologies for human leukocyte antigen (HLA).

From Luminex 8 Dec 2010

Transplant News and Research

HRSA ranks UCLA's heart transplant program as best in the U.S.

CTCs in metastatic breast cancer patients linked to cancer recurrence, poor survival rates

Researchers generate insulin-secreting pancreatic islet cells from human SSCs

Stem cell therapy can reduce risk of acute leukemia in affected individuals

Arizona's transplant funding cuts continue to trigger controversy; Florida, Kansas focus on state role in reforms; Wisc. plan would elminate tax on health savings accounts

OPTN arranges first paired donation of living donor kidneys

OpEds: Palin on the Ryan Roadmap, Seniors and primary care docs, Arizona transplant controversy

HeartWare prices public offering of convertible senior notes due 2017

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

Harvard Bioscience files two major patents in regenerative medicine

State roundup: Facing budget 'cliff'; Medicaid woes; Arizona transplant program; Another Florida health vote?

New three-drug combination may be effective for newly diagnosed blood cancer patients: Study

HeartWare announces $100 million convertible senior notes offering

Arizona State Dem. lawmakers push for restoring Medicaid transplant money

Bioheart group to advance BRIDGE TO RECOVERY clinical trial

Organovo releases data on bioprinted blood vessels

Lung transplant saves economist from near-lethal bout of swine flu

Three abstracts on Defibrotide presented at ASH Annual Meeting

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

One Lambda, Luminex renew 10-year human leukocyte antigen technology development partnership

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News